The downregulation of APOA1 is linked to increased tumor progression in cancers such as basal-like breast cancer and hepatocellular carcinoma, whereas overexpression of APOA1 has shown anti-proliferative and pro-apoptotic effects [75–77]. This evidence concerns the gene APOA1 and breast carcinoma.